Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2014 | 01-2014 | 10-2013 | 07-2013 | 04-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 651 | 364 | 339 | 345 | 319 |
| Receivables | 75 | 159 | 124 | 333 | 338 |
| Inventories | 128 | 133 | 87 | 85 | 72 |
| TOTAL | $901 | $699 | $625 | $838 | $804 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $1 | $1 | $1 | $1 | $1 |
| Total Assets | $901 | $700 | $626 | $840 | $805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40 | 64 | 26 | 38 | 27 |
| Accrued Expenses | 0 | 15 | 15 | N/A | 0 |
| TOTAL | $120 | $96 | $56 | $62 | $29 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 79 | 15 | 15 | 24 | 0 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $120 | $96 | $56 | $62 | $29 |
| Shareholders' Equity | |||||
| Retained earnings | -3,166 | -3,344 | -3,357 | -3,150 | -3,151 |
| Other shareholders' equity | 56 | 56 | 35 | 35 | 35 |
| TOTAL | $782 | $604 | $570 | $777 | $776 |
| Total Liabilities And Equity | $901 | $700 | $626 | $840 | $805 |